Enovis Corp
(NYSE:ENOV)
$
43.31
0.28 (0.65%)
Market Cap: 2.42 Bil
Enterprise Value: 3.79 Bil
PE Ratio: 0
PB Ratio: 0.72
GF Score: 71/100 Enovis Corp at Goldman Sachs Healthcare Conference Transcript
Jun 13, 2023 / 03:40PM GMT
Release Date Price:
$57.99
(+0.17%)
Jamie Aaron Perse
Goldman Sachs Group, Inc., Research Division - Associate
Good morning, everyone. I'm Jamie Perse. Thank you for joining Day 2 of the Goldman Healthcare Conference. Our next panel is with Enovis. We have CEO, Matt Trerotola, CFO, Ben Berry; and in the audience, we've got IR, Derek Leckow. Thank you for joining.
Matthew L. Trerotola
Enovis Corporation - CEO & Chairman
Thank you. Great to be here. Thanks.
Questions & Answers
Jamie Aaron Perse
Goldman Sachs Group, Inc., Research Division - Associate
Maybe we could start, I mean, I think investors are still getting up to speed on the company, and maybe you could just say a few words about the high-level story and where you guys are at today?
Matthew L. Trerotola
Enovis Corporation - CEO & Chairman
Yes, sure. Thanks. We're a focused med tech innovation-driven growth company, a little over $1.5 billion of revenues. We were created a little over a year ago by a separation from Colfax,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot